Angiotensin-converting enzyme inhibition reduces monocyte chemoattractant protein-1 and tissue factor levels in patients with myocardial infarction

1991, Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure, N Engl J Med, 325, 293, 10.1056/NEJM199108013250501 Pfeffer, 1992, Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial, N Engl J Med, 327, 669, 10.1056/NEJM199209033271001 1992, Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions, N Engl J Med, 327, 685, 10.1056/NEJM199209033271003 Nemerson, 1988, Tissue factor and hemostasis, Blood, 71, 1, 10.1182/blood.V71.1.1.1 Edgington, 1991, The structural biology of expression and function of tissue factor, Thromb Haemost, 66, 67, 10.1055/s-0038-1646375 Carson, 1993, The role of tissue factor in the production of thrombin, Blood Coagul Fibrinolysis, 4, 281, 10.1097/00001721-199304000-00010 Leatham, 1995, Increased monocyte tissue factor expression in coronary disease, Br Heart J, 73, 10, 10.1136/hrt.73.1.10 Suefuji, 1997, Increased plasma tissue factor levels in acute myocardial infarction, Am Heart J, 134, 253, 10.1016/S0002-8703(97)70132-7 Misumi, 1998, Comparison of plasma tissue factor levels in unstable and stable angina pectoris, Am J Cardiol, 81, 21, 10.1016/S0002-9149(97)00801-1 Soejima, 1996, Effect of enalapril on tissue factor in patients with uncomplicated acute myocardial infarction, Am J Cardiol, 78, 336, 10.1016/S0002-9149(96)00288-3 Annex, 1995, Differential expression of tissue factor protein in atherectomy specimens from patients with stable and unstable coronary syndromes, Circulation, 91, 619, 10.1161/01.CIR.91.3.619 Kaikita, 1997, Tissue factor expression on macrophages in coronary plaques in patients with unstable angina, Arterioscler Thromb Vasc Biol, 17, 2232, 10.1161/01.ATV.17.10.2232 Moreno, 1994, Macrophage infiltration in acute coronary syndromes, Circulation, 90, 775, 10.1161/01.CIR.90.2.775 Robinson, 1989, Complete amino acid sequence of a human monocyte chemoattractant, a putative mediator of cellular immune reactions, Proc Natl Acad Sci USA, 86, 1850, 10.1073/pnas.86.6.1850 Oppenheim, 1991, Properties of the novel proinflammatory supergene “intercrine” cytokine family, Ann Rev Immunol, 9, 617, 10.1146/annurev.iy.09.040191.003153 Nishiyama, 1998, Simultaneous elevation of the levels of circulating monocyte chemoattractant protein-1 and tissue factor in acute coronary syndromes, Jpn Circ J, 62, 710, 10.1253/jcj.62.710 Rao, 1987, Studies of a mechanism inhibiting the initiation of the extrinsic pathway of coagulation, Blood, 69, 645, 10.1182/blood.V69.2.645.645 Sandset, 1989, Factor VII and extrinsic pathway inhibitor in acute coronary disease, Br J Haematol, 72, 391, 10.1111/j.1365-2141.1989.tb07721.x Nishiyama, 1998, Heparin-releasable endothelial cell-associated tissue factor pathway inhibitor (TFPI) is increased in the coronary circulation after coronary spasm in patients with coronary spastic angina, Thromb Res, 89, 137, 10.1016/S0049-3848(97)00309-5 Wallenstein, 1988, Some statistical methods useful in circulation research, Circ Res, 47, 1, 10.1161/01.RES.47.1.1 Vaughan, 1997, Effects of ramipril on plasma fibrinolytic balance in patients with acute anterior myocardial infarction, Circulation, 96, 442, 10.1161/01.CIR.96.2.442 Soejima, 1997, Effects of imidapril therapy on endogenous fibrinolysis in patients with recent myocardial infarction, Clin Cardiol, 20, 441, 10.1002/clc.4960200507 Marmur, 1996, Identification of active tissue factor in human coronary atheroma, Circulation, 94, 1226, 10.1161/01.CIR.94.6.1226 Toschi, 1997, Tissue factor modulates the thrombogenicity of human atherosclerotic plaques, Circulation, 95, 594, 10.1161/01.CIR.95.3.594 Ardissino, 1997, Tissue-factor antigen and activity in human coronary atherosclerotic plaques, Lancet, 349, 769, 10.1016/S0140-6736(96)11189-2 Taubman, 1993, Agonist-mediated tissue factor expression in cultured vascular smooth muscle cells, J Clin Invest, 91, 547, 10.1172/JCI116234 Nishimura, 1997, Angiotensin II increases plasminogen activator inhibitor-1 and tissue factor mRNA expression without changing that of tissue type plasminogen activator or tissue factor pathway inhibitor in cultured rat aortic endothelial cells, Thromb Haemost, 77, 1189, 10.1055/s-0038-1656136 Nakamura, 1995, Clinical significance and use of tissue factor assay for blood samples, Jpn J Clin Hematol, 36, 263 Baja, 1990, Cultured normal human hepatocytes do not synthesize lipoprotein-associated coagulation inhibitor, Proc Natl Acad Sci USA, 87, 8869, 10.1073/pnas.87.22.8869 Enjyoji, 1992, cDNA cloning and expression of rat tissue factor pathway inhibitor (TFPI), J Biochem, 111, 681, 10.1093/oxfordjournals.jbchem.a123818 Sandset, 1988, Heparin induces release of extrinsic coagulation pathway inhibitor (EPI), Thromb Res, 50, 803, 10.1016/0049-3848(88)90340-4 Novotny, 1991, Purification and properties of heparin releasable lipoprotein associated inhibitor, Blood, 78, 394, 10.1182/blood.V78.2.394.394 Lindahl, 1990, Extrinsic pathway inhibitor after heparin injection, Thromb Res, 59, 651, 10.1016/0049-3848(90)90423-A Lindahl, 1991, Tissue factor pathway inhibitor with high anticoagulant activity is increased in post-heparin plasma and in plasma from cancer patients, Blood Coagul Fibrinolysis, 2, 713, 10.1097/00001721-199112000-00004 Kokawa, 1996, Measurement of the free form of TFPI antigen in hyperlipidemia, Arterioscler Thromb Vasc Biol, 16, 802, 10.1161/01.ATV.16.6.802 Caplice, 1998, Presence of tissue factor pathway inhibitor in human atherosclerotic plaques is associated with reduced tissue factor activity, Circulation, 98, 1051, 10.1161/01.CIR.98.11.1051 Oltrona, 1997, Inhibition of tissue factor-mediated coagulation markedly attenuates stenosis after balloon-induced arterial injury in minipigs, Circulation, 96, 646, 10.1161/01.CIR.96.2.646 Falciani, 1998, Elevated tissue factor and tissue factor pathway inhibitor circulating levels in ischaemic heart disease patients, Thromb Haemost, 79, 495, 10.1055/s-0037-1614932 Rollins, 1990, Cytokine-activated human endothelial cells synthesize and secrete a monocyte chemoattractant, MCP-1/JE, Am J Pathol, 136, 1229 Badolato, 1997, Interleukin-15 (IL-15) induces IL-8 and monocyte chemotactic protein 1 production in human monocytes, Blood, 90, 2804, 10.1182/blood.V90.7.2804 Marumo, 1997, Platelet-derived growth factor-stimulated superoxide anion production modulates activation of transcription factor NF-κB and expression of monocyte chemoattractant protein-1 in human aortic smooth muscle cells, Circulation, 96, 2361, 10.1161/01.CIR.96.7.2361 Ernofsson, 1996, Platelet-derived growth factor-BB and monocyte chemotactic protein-1 induce human peripheral blood monocytes to express tissue factor, Thromb Res, 83, 307, 10.1016/0049-3848(96)00139-9 Matsumori, 1997, Plasma levels of the monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 are elevated in patients with acute myocardial infarction, J Mol Cell Cardiol, 29, 419, 10.1006/jmcc.1996.0285 Hernández-Presa, 1997, Angiotensin-converting enzyme inhibition prevents arterial nuclear factor-κB activation, monocyte chemoattractant protein-1 expression, and macrophage infiltration in a rabbit model of early accelerated atherosclerosis, Circulation, 95, 1532, 10.1161/01.CIR.95.6.1532